Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Got Gold Report: COMEX commercials halt silver advance

ATLANTA – We are going to let the charts do most of the “talking” in this offering of the Got Gold Report - in a new, much shorter format. Pressure on the euro eased, the U.S. dollar index corrected lower, both gold and silver saw profit taking (espec...
Gene Arensberg | October 28, 2012 |

Buzz on the Bullboards: Rate hikes and you

News for traders this week has revolved around the Federal Reserve raising its benchmark interest rate by three-quarters of a point for a fourth straight time.
Jonathon Brown | November 3, 2022 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

This Billionaire Says Gold Has Everything Going For It

Last week was a strong one for gold, which managed to eke out its fourth straight week of positive gains. The price of the yellow metal broke above $1,350 an ounce last Friday, while gold miners, as measured by the NYSE Arca Gold Miners Index, tested their 52-week high. ...
Frank Holmes | June 17, 2019 |

Got Gold Report: Natural gas cheap again

ATLANTA -- The natural gas producers in North America have done such a good job at telling us how plentiful the clean-burning resource is that NatGas has become one of the cheapest of energy sources around – again. We intend to focus on that exclusively in this one-time spec...
Gene Arensberg | October 28, 2012 |

Gold Stocks Are Overbought. You Don’t Want Prices to Go Straight Up

Bill Powers of MiningStockEducation.com talks with a professional trader and market commentator Chris Vermeulen says gold stocks are overbought and need a breather which would be good for the overall upward trend. Chris shares how he has and is trading the junior gold ...
Chris Vermeulen | May 22, 2020 |

What’s with all the weird weather?

In January 2018, something strange happened in the Sahara Desert: it snowed . The Algerian town of Ain Sefra, named the “Gateway to the Sahara”, reportedly received up to an inch, barely enough to get the average North American out of bed early to scra...
Richard (Rick) Mills | July 19, 2019 |

Interference Most Foul: When Speculation Becomes Reality

To put it mildly, the business of financial forecasting is not only an inexact science, it is a magnified case study in handicapping, the likes of which you find in sports betting such as horse racing or basketball. You take a basket of data inputs, such as the last fiv...
Streetwise Reports | October 28, 2019 |

Insider Tips From a Capital Markets Guru on Trends

When it comes to capital markets, there are few more experienced to teach the do’s and don’ts of trading than Howard Katz – Managing Director of Mackie Research. In this insightful, intriguing and entertaining interview with Dave Jackson of...
Dave Jackson | August 27, 2020 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |
1 2 3 4 5 6 7 8 9 10 ...